Wolff-Parkinson-White Syndrome Concomitant with Asymptomatic Brugada Syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 1, 2004, Pages 109-111

  Ohkubo, Kimie ^a   Watanabe, Ichiro ^a   Okumura, Yasuo ^a   Yamada, Takeshi ^a   Hashimoto, Kenichi ^a   Masaki, Riko ^a   Oshikawa, Naohiro ^a   Kofune, Tatsuya ^a   Wakita, Rie ^a   Takagi, Yasuhiro ^a   Saito, Satoshi ^a   Ozawa, Yukio ^a   Kanmatsuse, Katsuo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Brugada syndrome; Wolff Parkinson White syndrome

Indexed keywords

CIBENZOLINE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; ELECTROLYTE BLOOD LEVEL; ELECTROPHYSIOLOGY; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PHYSICAL EXAMINATION; QRS COMPLEX; THORAX RADIOGRAPHY; WOLFF PARKINSON WHITE SYNDROME;

ADULT; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HUMANS; MALE; TACHYCARDIA; VENTRICULAR FIBRILLATION; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 9144231196     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00396.x     Document Type: Article

References (14)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20:1391-1396.
2. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002; 40:330-334.
3. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392:293-296.
4. Eckardt L, Kirchof P, Loh P, et al. Brugada syndrome and supraventricular tachyarrhythmias: A novel association? J Cardiovasc Electrophysiol 2001; 12:680-685.
5. Ikeda T, Sakurada S, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: Insight into risk stratification. J Am Coll Cardiol 2001; 37:1628-1634.
6. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
7. Masaki R, Watanabe I, Nakai T, et al. Role of signal-averaged electrocardiograms for predicting the inducibility of ventricular fibrillation in the syndrome of right bundle branch block and ST segment elevation in leads V1-V3. Jpn Heart J 2002; 43:367-378.
8. Eckardt L, Kirchhof P, Johna R, et al. Wolff-Parkinson-White syndrome associated with Brugada syndrome. PACE 2001; 24:1423-1424.
9. Bodegas AI, Arana JI, Arriandiaga JR, et al. Brugada syndrome in a patient with accessory pathway. Europace 2002; 4:87-89.
10. Itoh H, Shimizu M, Ino H, et al. Arrhythmias in patients with Brugada-type electrocardiographic findings. Jpn Circ J 2001; 65:483-486.
11. Osaka T, Yokoyama E, Yamazaki M, et al. Intraatrial conduction abnormalities in patients with Brugada-type ECG estimated by P wave triggered signal-averaged ECG. J Am Coll Cardiol 2002; 39(Suppl. A):110A.
12. Morita H, Nagase S, Hisamatsu K, et al. Atrial fibrillation and atrial vulnerability in patients with the Brugada syndrome. PACE 2002; 24:610.
13. Antzelevitch C, Brugada P, Brugada L, et al. The Brugada Syndrome. In J Camm (ed.): Clinical Approaches to Tachyarrhythmias. Armonk, NY, Futura Publishing Co, 1999, p. 70.
14. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101:510-515.